Over the years, there have been notable improvements in the diagnosis and treatment of breast cancer, one of the most common malignancies in the world. Despite these developments, controlling the serious side effects of breast cancer treatments remains a challenge. In addition to lowering patients’ quality of life, these adverse effects—which can range from nausea and fatigue to potentially fatal complications—can also have an impact on treatment compliance and results. A promising approach to tackling this issue is pharmacogenomics, the study of how a person’s genetic composition affects how they react to medications. Pharmacogenomics seeks to customize therapies to each patient’s unique genetic profile by enabling customized therapy, maximizing effectiveness while reducing side effects.
Understanding Pharmacogenomics
To comprehend how genetic variants affect drug metabolism, efficacy, and safety, pharmacogenomics integrates the fields of pharmacology (the study of drugs). with genomics (the study of genes and their roles). The way a patient’s body reacts to various drugs can be affected by variations in particular genes. Certain genetic variations, for instance, may result in slower drug digestion, which raises the possibility of side effects and causes pharmaceuticals to build up in the body. On the other hand, a fast metabolism could make a medication less effective.
Pharmacogenomics is the study of genetic markers that predict a patient’s reaction to hormone therapies, chemotherapy, and targeted treatments in the context of breast cancer. To get the best results for every patient, this helps doctors to choose the best treatment plans, modify dosages, or look into alternative therapies.
Pharmacogenomics' Function in the Treatment of Breast Cancer
1. Better Selection of Drugs
The ability of pharmacogenomics to inform drug selection is among its most important contributions. Clinicians can determine which treatments are most likely to work for a given patient by discovering genetic markers linked to drug response.
